Please Note: This trial is no longer enrolling new participants
A randomized, double-blind, multicenter, Phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD)
Protocol No. | CTO-EFC17757 | Scope | National |
---|---|---|---|
Principal Investigator | Jennifer Schwartz | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase III |